CVS

CVS HEALTH
D

CVS

Arincen56/100B

CVS HEALTH net income 1985–2026

CVS HEALTH earned 2.17B USD in Q3 FY2026, the three months to 30 September 2026, against a loss of 3.98B USD on the same quarter a year before. CVS HEALTH's net income over the last twelve months was 11.05B USD, up 2,256.7% on the twelve months before. In fiscal year 2025 it earned 1.77B USD, down 61.7% on the year before.

Last updated 6 Nov 2026 · Next report 9 Feb 2027

Net income

Net income · -10.3% a year over 10 yearsNet margin

Growth

Fiscal yearPeriod endingNet incomeGrowthNet marginRevenue
TTM30 Sept 202611.05B+2,256.72%2.63%420.61B
FY202531 Dec 20251.77B-61.68%0.44%402.07B
FY202431 Dec 20244.61B-44.70%1.24%372.81B
FY202331 Dec 20238.34B+93.55%2.33%357.78B
FY202231 Dec 20224.31B-46.12%1.34%322.47B
FY202131 Dec 20218.00B+11.45%2.74%292.11B
FY202031 Dec 20207.18B+8.22%2.67%268.71B
FY201931 Dec 20196.63B—2.58%256.78B
FY201831 Dec 2018-594.00M-108.97%-0.31%194.58B
FY201731 Dec 20176.62B+24.54%3.58%184.79B
FY201631 Dec 20165.32B+1.53%2.99%177.55B
FY201531 Dec 20155.24B+12.77%3.42%153.29B
FY201431 Dec 20144.64B+1.13%3.33%139.37B
FY201331 Dec 20134.59B+18.84%3.62%126.76B
FY201231 Dec 20123.86B+11.61%3.14%123.12B
FY201131 Dec 20113.46B+1.02%3.23%107.08B
FY201031 Dec 20103.43B-7.28%3.58%95.78B
FY200931 Dec 20093.70B+15.07%3.76%98.22B
FY200831 Dec 20083.21B+21.81%3.67%87.47B
FY200731 Dec 20072.64B+92.64%3.45%76.33B
FY200631 Dec 20061.37B+11.77%3.12%43.82B
FY200531 Dec 20051.22B+33.29%3.31%37.01B
FY200431 Dec 2004918.80M+8.44%3.00%30.59B
FY200331 Dec 2003847.30M+18.24%3.19%26.59B
FY200231 Dec 2002716.60M+73.43%2.96%24.18B
FY200131 Dec 2001413.20M-44.61%1.86%22.24B
FY200031 Dec 2000746.00M+17.46%3.71%20.09B
FY199931 Dec 1999635.10M+65.18%3.51%18.10B
FY199831 Dec 1998384.50M+333.00%2.52%15.27B
FY199731 Dec 199788.80M-57.35%0.65%13.75B
FY199631 Dec 1996208.20M—1.76%11.83B
FY199531 Dec 1995-572.80M-286.28%-5.87%9.76B
FY199431 Dec 1994307.50M-7.32%2.72%11.29B
FY199331 Dec 1993331.80M+148.73%3.18%10.44B
FY199231 Dec 1992133.40M-61.52%1.28%10.43B
FY199131 Dec 1991346.70M-10.02%3.51%9.89B
FY199031 Dec 1990385.30M-3.22%4.44%8.69B
FY198931 Dec 1989398.10M+12.30%5.27%7.55B
FY198831 Dec 1988354.50M+24.21%5.23%6.78B
FY198731 Dec 1987285.40M+19.77%4.81%5.93B
FY198631 Dec 1986238.30M+13.37%4.53%5.26B
FY198531 Dec 1985210.20M—4.40%4.77B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about CVS HEALTH's profit

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.